Cargando…
A Targeted in Vivo SILAC Approach for Quantification of Drug Metabolism Enzymes: Regulation by the Constitutive Androstane Receptor
[Image: see text] The modulation of drug metabolism enzyme (DME) expression by therapeutic agents is a central mechanism of drug–drug interaction and should be assessed as early as possible in preclinical drug development. Direct measurement of DME levels is typically achieved by Western blotting, q...
Autores principales: | MacLeod, A. Kenneth, Zang, Tuo, Riches, Zoe, Henderson, Colin J., Wolf, C. Roland, Huang, Jeffrey T.-J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2013
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3923450/ https://www.ncbi.nlm.nih.gov/pubmed/24303842 http://dx.doi.org/10.1021/pr400897t |
Ejemplares similares
-
An Enhanced In Vivo Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) Model for Quantification of Drug Metabolism Enzymes
por: MacLeod, A. Kenneth, et al.
Publicado: (2015) -
Constitutive androstane receptor 1 is constitutively bound to
chromatin and ‘primed’ for transactivation in hepatocytes
por: McMahon, Michael, et al.
Publicado: (2019) -
Signaling control of the constitutive androstane receptor (CAR)
por: Yang, Hui, et al.
Publicado: (2014) -
Noncanonical Constitutive Androstane Receptor Signaling in Gene Regulation
por: Pustylnyak, Yuliya A., et al.
Publicado: (2020) -
Metabolism-Disrupting Chemicals and the Constitutive Androstane Receptor CAR
por: Küblbeck, Jenni, et al.
Publicado: (2020)